Skip to Content Skip to Search

Breo Ellipta

Active Ingredient: fluticasone furoate and vilanterol (trifenatate)

Consumer Medicine Information

The Consumer Medicine Information is a leaflet written for people who have been prescribed this product. This information is intended for use in Australia only and does not replace advice from a healthcare professional. You should discuss the CMI with your healthcare professional if you have any questions or concerns.

Download Breo Ellipta CMI (PDF-79.5KB)

Product Information

The Product Information is intended to assist healthcare professionals make decisions about treatment options and provide advice on the appropriate use of a medicine to patients. This information only applies to GSK products available in Australia.

Download Breo Ellipta PI (PDF-880KB)